OBJECTIVE—The aim of the present study was to evaluate serum and urinary nitric oxide (NO) concentrations in children and adolescents with diabetes compared with age-matched healthy control subjects to find out whether Doppler ultrasonography could be used to detect changes in renal resistive indexes (RIs) in children with diabetes and to assess whether there are correlations between these parameters and NO excretion.

RESEARCH DESIGN AND METHODS—We studied 42 children with type 1 diabetes and 41 matched healthy control subjects, both divided into prepubertal or pubertal children. Serum and urinary nitrite and nitrate (NO2+NO3) concentrations were evaluated as an index of NO production. Doppler ultrasonographic registration of intrarenal RI was performed.

RESULTS—Compared with healthy control subjects, children with diabetes had significantly increased concentrations of serum (30.26 ± 6.52 vs. 24.47 ± 7.27 mmol/l, P = 0.001) and urinary NO2+NO3 (345.07 ± 151.35 vs. 245.86 ± 80.25 mmol/l, P = 0.002); the same was true for Doppler RI values (0.64 ± 0.03 vs. 0.60 ± 0.04, P = 0.035). This occurs in both prepubertal and the pubertal children. A significant positive correlation was found between serum and urinary NO2+NO3 levels (P = 0.002, r = 0.374). Serum NO2+NO3 concentrations also correlated positively with Doppler RI (P = 0.032, r = 0.262) and HbA1c (A1C) (P = 0.004, r = 0.329); urinary NO2+NO3 concentrations correlated positively with A1C (P = 0.001, r = 0.394). Doppler RI correlated positively with A1C (P = 0.000, r = 0.424).

CONCLUSIONS—This study demonstrates that in children with diabetes, chronic hyperglycemia may act through a mechanism that involves increased NO production and/or action and contributes to generating intrarenal hemodynamic abnormalities, which are detectable by Doppler ultrasonography even in early diabetic nephropathy.

Clinically evident diabetes-related microvascular complications are extremely rare in childhood and adolescence. Nonetheless, early functional and structural abnormalities may be present a few years after the onset of the disease. Chronic hyperglycemia is central in the pathophysiology of microangiopathy and in the evolution of diabetes complications, such as diabetic nephropathy. It sets in motion a series of biochemical disturbances in critical tissue, including the kidney, leading to functional changes followed by irreversible structural changes, and finally to the features that we recognize as clinical disease (13). Hyperglycemia is associated with excessive free radical generation and oxidant stress and reduction in the antioxidant status. One of the many consequences of oxidant stress that has been linked to diabetes is altered nitric oxide (NO) production and action (4). NO, an endothelium-derived relaxing factor, has been identified as a pleiotropic intercellular messenger that regulates a variety of cellular functions (5). All isoforms of NO synthase have been isolated in the renal proximal tubular cells. Vasodilatation due to increased NO generation or action has recently been implicated in the genesis of glomerular hyperfiltration and in the enhanced permeability to macromolecules, which leads to microalbuminuria. A glucose-dependent abnormality in NO production and action has therefore become an attractive hypothesis for the pathogenesis of early diabetic nephropathy (1,68).

For some years, Doppler ultrasonography has provided an easily applicable and noninvasive method for investigating renal hemodynamic. The renal resistive index (RI), determined by Doppler ultrasonography, reflects intrarenal vascular resistance (9). Increased intrarenal RI has recently been shown in adults with diabetic nephropathy as a function of creatinine clearance, age, and diabetes duration (10,11) and could represent a useful indication of renal function in diabetic kidney disease, especially in advanced clinical diabetic nephropathy (12). However, data on RI in children and adolescents with diabetes are still lacking, and the correlation between increased intrarenal RI and altered renal hemodynamics remains unclear.

The aim of the present study was to evaluate serum and urinary NO concentrations in children and adolescents with diabetes compared with age-matched healthy control subjects to find out whether Doppler ultrasonography could be used to detect changes in renal RI in children with diabetes and to assess whether there are correlations between these parameters and NO excretion.

We recruited 42 Caucasian children with type 1 diabetes (22 boys and 20 girls, aged 6–18 years) who attended the Diabetic Centre of the Department of Pediatrics, University of Chieti, Italy, between November 2002 and March 2003. All subjects were otherwise in good health; none had clinical or laboratory signs of kidney disease or microalbuminuria; none were affected by other complications of diabetes, such as retinopathy (evaluated by stereoscopic fundus photography) or neuropathy (evaluated by nervous conduction velocity and autonomic tests), or by other autoimmune disease. None of the patients were taking other drugs except for insulin. Daily insulin requirement was assessed. All subjects were assigned into the prepubertal or pubertal group on the basis of breast development in girls and genital development in boys, according to the criteria of Tanner. Prepubertal children were defined as Tanner stage 1 (10 boys and 10 girls, mean ± SD age 9.75 ± 2.02 years, mean duration of diabetes 5.50 ± 2.39 years) and pubertal as Tanner stages 2–5 (12 boys and 10 girls, mean age 14.63 ± 1.39 years, mean duration of diabetes 8.50 ± 3.30 years). We recruited, as a control group, 41 Caucasian children comparable for sex, age, and pubertal stage and divided them into prepubertal (11 boys and 10 girls, mean age 9.52 ± 1.94 years) and pubertal (10 boys and 10 girls, mean age 14.75 ± 1.29 years) who were admitted to the Department of Pediatrics of the University of Chieti, Italy, for minor diseases. Blood sampling, anthropometric measurements, and Doppler ultrasonographic evaluation was performed only after complete recovery of the disease. All patients, or their parents, gave informed consent. The study was approved by the ethics committee of the University of Chieti, Italy.

Anthropometric measurements

Body weight was measured with a digital scale to the nearest 0.1 kg, and height was measured in triplicate with a wall-mounted stadiometer. The BMI (weight in kilograms divided by the square of the height in meters) was assessed as the fatness index. Blood pressure was measured by auscultation with a standard mercury sphygmomanometer in a quiet and comfortable environment after 3–5 min of rest. The cuff size was appropriate for the size of the 40% of the arm circumference midway between the olecron and the acromion, according to the recommendations of the Task Force on Blood Pressure Control in Children (13).

Biochemical analysis

Blood samples were collected in fasting conditions and immediately centrifuged at 4°C. Plasma glucose level was determined by using the glucose oxidase method. HbA1c (A1C) concentrations were measured every 3 months using a high-performance liquid chromatography method (Diamant analyser; BioRad, Richmond, CA). The normal range was 4.2–6.0%, with an intrassay coefficient of variation (CV) of 3%. All the patients had at least three determinations per year, and the mean of these determinations was used for statistical analysis. The creatinine concentration was measured by an autoanalyzer (Astra 8; Beckam Instruments/Hybritech, Palo Alto, CA). Urinary albumin concentration was measured by double-antibody radioimmunoassay (Pharmacia, Uppsala, Sweden) with a sensitivity 0.5 mg/l, an intra-assay CV of 4.5%, and an interassay CV of 5.3% in the range of 10–50 mg/l. None of the children with diabetes had persistent microalbuminuria (defined as an albumin excretion rate >20 μg/min in two of three overnight urine collections in 6 months). Glomerular filtration rate (GFR) was assessed using radionuclide-imaging studies with 99mtechnetium dimetiltriamino pentacetic acid, as previously described (14).

NO assay

In the cell, NO undergoes a series of reactions with several molecules present in biological fluids and is eventually metabolized to nitrite (NO2) and nitrate (NO3). Thus, the best index of total NO production is the sum of both nitrite and nitrate, commonly quantified in a two-step assay (15). In this study, serum NO2+NO3 levels were measured in triplicate by the conversion of NO3 to NO2 by a commercially available kit based on the Griess reaction (active motif’s NO quantitation kit), following the manufacturer’s instructions. Blood samples were collected in fasting conditions, and serum nitrite (NO2) and nitrate (NO3) concentrations were measured as previously reported (16). NO urinary metabolites were evaluated in the overnight urine collection; for each patient, 50 μl antioxidant solution was added to 40 ml fresh overnight urine and frozen at −20°C. Nitrite (NO2) and nitrate (NO3) contents were evaluated with the nitrate reductase method.

The children’s eating habits reflect the typical Mediterranean diet. Consumption of foods containing nitrates (e.g., spinach, beets, cabbage, cauliflower, beetroot, and lettuce) was discouraged for the 48 h preceding the measurements to avoid the dietary influence of NO assay.

Doppler ultrasonographic evaluation

The measurements were commenced in patients fasting for at least 8 h, after recording pulse and blood pressure. All the examinations were performed using a 3.5–4.0 MHz vector array transducer, after 15 min rest in a horizontal position, as previously described (10). The first measurement was the size of the left and right kidney. The main trunk of the renal artery was displayed using color Doppler ultrasonography. Three measurements each were taken within 5 min in the vicinity of the interlobary artery at the boundary of the center of the kidney and the upper and lower pole using pulsed Doppler. The RI, according to Pourcelot, was calculated on the basis of the following formula: [(peak systolic velocity − peak diastolic velocity)/peak systolic velocity].

The average value of three bilateral measurements was taken for statistical analysis. All the examinations were performed twice by the same operator, without knowledge of the patient group (case or control).

Statistical analysis

All values are expressed as means ± SD. Differences in unpaired samples were examined by Mann-Whitney testing. A P value of 0.05 was considered statistically significant. Correlation between variables was evaluated using Pearson’s correlation coefficient. Data input and basic evaluation were carried out using the SPSS version 10.0 software.

Clinical characteristics of subjects are summarized in Tables 1 and 2. Children with and without diabetes, both prepubertal and pubertal, did not differ in sex, age, and BMI. Children with diabetes had significantly increased values of GFR compared with control subjects (144.94 ± 42.49 vs. 128.30 ± 15.94 ml/min, respectively, P = 0.005).

Serum and urinary NO concentrations were significantly increased in children with diabetes compared with control subjects (30.26 ± 6.52 vs. 24.47 ± 7.27 mmol/l, respectively, P = 0.001). In particular, prepubertal children with diabetes had significantly higher NO2+NO3 serum levels than prepubertal healthy children (30.88 ± 7.33 vs. 25.13 ± 8.06 mmol/l, P = 0.026); the same findings weree detected in the pubertal group (29.68 ± 5.79 vs. 23.74 ± 6.43 mmol/l, P = 0.012). Urinary NO2+NO3 levels were significantly higher in children with diabetes (345.07 ± 151.35 vs. 245.86 ± 80.25 mmol/l, P = 0.002) in both the prepubertal (296.47 ± 110.45 vs. 238.39 ± 59.37 mmol/l, P = 0.046) and pubertal (391.12 ± 172.31 vs. 296.85 ± 131.12 mmol/l, P = 0.013) groups.

Doppler RI was significantly higher in children with diabetes than in healthy control children (0.64 ± 0.03 vs. 0.60 ± 0.04, respectively, P = 0.035) in both the prepubertal (0.65 ± 0.04 vs. 0.61 ± 0.05, P = 0.014) and the pubertal (0.64 ± 0.03 vs. 0.60 ± 0.03, P = 0.002) groups.

In the diabetic group, a significant positive correlation between serum NO2+NO3 levels and urinary NO2+NO3 levels (P = 0.002, r = 0.374) was found. Serum NO2+NO3 concentrations also correlated positively with A1C (P = 0.004, r = 0.329), GFR (P = 0.05, r = 0.224), and Doppler RI (P = 0.032, r = 0.262). Urinary NO2+NO3 concentrations correlated positively with A1C (P = 0.001, r = 0.394) and GFR (P = 0.0001, r = 0.480). Doppler RI correlated positively with A1C (P = 0.000, r = 0.424) and diabetes duration (P = 0.020, r = 0.386) (Table 3). There were no correlations in the control group, neither for serum and urinary NO2+NO3 nor for Doppler RI values (Fig. 1). No sex differences in NO results or Doppler RI were found.

It has been clearly demonstrated that hyperglycemia is directly related to hyperfiltration and renal hyperperfusion (17), and it has been causally linked to vascular and glomerular dysfunction. There is no shortage of plausible biochemical mechanisms that could lead to functional changes and/or tissue damage. A glucose-dependent abnormality in NO production and action has recently been the subject of extensive investigation. Diabetes triggers mechanisms that in parallel enhance and suppress NO bioavailability in the kidney. During the early phase of nephropathy, the balance between these two opposing forces is shifted toward NO production. This plays a pivotal role in the development of characteristic hemodynamic changes and may contribute to consequent structural alteration in the glomeruli (18). Nonetheless, alterations of the NO system in the diabetic kidney and their role in the pathophysiology of diabetic nephropathy still represent a complex and controversial scenario; many important mechanisms can comodulate NO activity in a particular system (e.g., glycemic control, insulin treatment, duration of the disease, development of diabetes complications), and there are a number of topics in this area that warrant further investigation. In the present study, serum and urinary NO2+NO3 levels were found to be significantly increased in children with diabetes compared with healthy subjects and showed a significantly positive correlation with A1C and GFR. This was detected in prepubertal and pubertal children, supporting the hypothesis that enhanced NO production occurs at the earliest stages of diabetic nephropathy, before microalbuminuria appears, and is independent from diabetes duration and puberty. However, other investigators (19) found decreased levels of the same parameters. Puberty has been recognized as a major risk factor for the development of microangiopathy in children with diabetes, although it is not necessarily associated with the progression to frank proteinuria. It accelerates microvascular complications of diabetes, but prepubertal years of hyperglycemia appear to contribute to its development (20). The onset of microvascular complications can be presumed to start very early in the course of diabetes, perhaps at the disease onset, and the earliest stages can be often detected as soon as 2–5 years after diagnosis (21). Accordingly, in this study, both pubertal and prepubertal children with diabetes have higher NO values than healthy control subjects, suggesting no effect of puberty.

Histologically, basal membrane thickening seems to have the major predictive value to estimate the risk of disease progression (22), but it is unthinkable to implement invasive methods, such as renal biopsy, for screening purposes, especially in children. Doppler ultrasonography seems to be a reliable method for renal explorations by providing not only morphological but also physiological data with the perfusion study. The Doppler RI [(peak systolic velocity − peak diastolic velocity)/peak systolic velocity] has advanced as a useful parameter for quantifying the alteration in renal blood flow that may occur with renal disease. It reflects intrarenal vascular resistance, which is markedly linked to vascular compliance. Elevated RIs were reported with vascular-interstitial disease, including diabetic nephropathy (but not glomerulopathies); this may be due to the decreased tissue and vascular compliance and to the increased renal vascular resistance (23,24). Early functional and structural abnormalities present after a few years of diabetes might be responsible for the precocious alteration in renal hemodynamics, and this might be reflected in increased RI. Nonetheless, only few studies describing the application of Doppler ultrasonography in the evaluation of intrarenal hemodynamic abnormalities in diabetic nephropathy have been published, and most of them were performed in adults with type 1 or type 2 diabetes (9,10). Recently, a study evaluated the role of renal Doppler ultrasonography as a predictor of preclinical diabetic nephropathy in children and documented that ultrasonography is not useful for the prediction and detection of early diabetic nephropathy (25); however, there is no general agreement for the predictive value of Doppler ultrasonography in patients with diabetic nephropathy (12,2528).

In the present study, we wanted to assess whether Doppler ultrasonography could be used to detect changes in renal RI in children with diabetes, the correlations between these parameters, and whether the increased NO excretion might exist. We observed that children with diabetes had significantly increased values of Doppler RI compared with healthy control subjects, although all the RI values (in diabetic and healthy children) were ≤0.70, which is actually accepted as the boundary normal RI value for healthy adults and children (29). This was found in the prepubertal and pubertal children with diabetes, all having normal renal function. Increased RI correlates positively with A1C, duration of diabetes, and NO excretion. No correlation between NO and RI was found in the control groups.

The significant positive association between NO and Doppler RI in children with diabetes suggests that precocious abnormality in NO production and action occurring early in the course of the disease may have contributed to the loss of maintaining the normal state of vascular tone and, thus, to the higher starting RI values. At the single-nephron level, diabetic hyperfiltration is characterized by disproportionately decreased afferent arteriolar resistance, resulting in elevated glomerular capillary pressure; this might be reflected in the increased RI. Considering the renal hemodynamic actions of NO, this substance is a good candidate for mediating diabetic hyperfiltration (18).

In conclusion, this study demonstrates that in children with diabetes, chronic hyperglycemia may act through a mechanism that involves increased NO production and/or action and contributes to generating intrarenal hemodynamic abnormalities, detectable by Doppler ultrasonography even in early diabetic nephropathy before microalbuminuria appears, and acts independently from duration of diabetes and puberty. Although our data have to be confirmed in further longitudinal studies, they suggest that evaluation of NO excretion and Doppler intrarenal RI may be a useful complementary test in the evaluation of early stages of diabetic kidney disease. Longitudinal monitoring of a panel of laboratory markers, such as those used in the current study, may better define their relevance in progressive kidney disease and provide greater insight into the mechanisms underlying this process.

Figure 1—

Relations between mean value of A1C and serum NO2 + NO3 (A), urinary NO2 + NO3 (B), and mean RI (mRI) (C) in 42 children with diabetes.

Figure 1—

Relations between mean value of A1C and serum NO2 + NO3 (A), urinary NO2 + NO3 (B), and mean RI (mRI) (C) in 42 children with diabetes.

Close modal
Table 1—

Characteristics of diabetic and control children

Diabetic subjectsControl subjectsP
n 42 41  
Auxology    
    Sex (female/male) 20/22 20/21  
    Age (years) 12.31 ± 2.30 12.07 ± 3.11 0.710 
    BMI (kg/m221.78 ± 3.70 20.11 ± 3.12 0.620 
Laboratory tests    
    Glycemia (mg/dl) 213.29 ± 92.03 76.7 ± 8.09 0.000* 
    A1C (%) 7.43 ± 1.04 5.09 ± 0.26 0.000* 
    Serum creatinine (mg/dl) 0.62 ± 0.12 0.67 ± 0.15 0.180 
    AER (μg/min) 6.69 ± 3.93 6.91 ± 3.16 0.423 
    GFR (ml/min) 144.94 ± 42.49 128.30 ± 15.94 0.005* 
NO    
    Serum NO (mmol/l) 30.27 ± 6.52 24.47 ± 7.27 0.001* 
    Urinary NO (mmol/l) 345.07 ± 151.35 245.86 ± 80.25 0.002* 
Doppler mRI 0.64 ± 0.03 0.60 ± 0.04 0.000* 
Diabetic subjectsControl subjectsP
n 42 41  
Auxology    
    Sex (female/male) 20/22 20/21  
    Age (years) 12.31 ± 2.30 12.07 ± 3.11 0.710 
    BMI (kg/m221.78 ± 3.70 20.11 ± 3.12 0.620 
Laboratory tests    
    Glycemia (mg/dl) 213.29 ± 92.03 76.7 ± 8.09 0.000* 
    A1C (%) 7.43 ± 1.04 5.09 ± 0.26 0.000* 
    Serum creatinine (mg/dl) 0.62 ± 0.12 0.67 ± 0.15 0.180 
    AER (μg/min) 6.69 ± 3.93 6.91 ± 3.16 0.423 
    GFR (ml/min) 144.94 ± 42.49 128.30 ± 15.94 0.005* 
NO    
    Serum NO (mmol/l) 30.27 ± 6.52 24.47 ± 7.27 0.001* 
    Urinary NO (mmol/l) 345.07 ± 151.35 245.86 ± 80.25 0.002* 
Doppler mRI 0.64 ± 0.03 0.60 ± 0.04 0.000* 

Data are means ± SD.

*

P ≤ 0.05. AER, albumin excretion rate; mRI, mean RI.

Table 2—

Characteristics of prepubertal and pubertal patients

Prepubertal
Pubertal
Diabetic subjectsControl subjectsPDiabetic subjectsControl subjectsP
n 20 21  22 20  
Auxology       
    Sex (female/male) 10/10 10/11  10/12 10/10  
    Age (years) 9.75 ± 2.02 9.52 ± 1.94 0.662 14.64 ± 1.39 14.75 ± 1.29 0.886 
    BMI (kg/m219.70 ± 2.18 18.60 ± 2.25 0.061 23.47 ± 3.87 21.54 ± 3.19 0.128 
Laboratory tests       
    Glycemia (mg/dl) 203.35 ± 77.96 76.43 ± 8.95 0.000* 222.76 ± 104.75 77.00 ± 7.30 0.000* 
    A1C (%) 7.26 ± 0.69 5.19 ± 0.19 0.000* 7.57 ± 1.28 4.99 ± 0.29 0.000* 
    Serum creatinine (mg/dl) 0.54 ± 0.06 0.56 ± 0.07 0.734 0.69 ± 0.12 0.79 ± 0.10 0.016* 
    AER (μg/min) 5.68 ± 1.72 5.03 ± 2.87 0.090 7.83 ± 5.27 8.89 ± 2.08 0.156 
    GFR (ml/min) 142.75 ± 14.22 136.60 ± 16.38 0.188 146.93 ± 57.73 119.58 ± 9.1 0.013* 
NO       
    Serum NO (mmol/l) 30.88 ± 7.33 25.13 ± 8.06 0.026* 29.68 ± 5.79 23.74 ± 6.43 0.012* 
    Urinary NO (mmol/l) 296.47 ± 110.45 238.39 ± 59.37 0.046* 391.12 ± 172.31 296.85 ± 131.12 0.013* 
Doppler mRI 0.65 ± 0.04 0.61 ± 0.05 0.014* 0.64 ± 0.03 0.60 ± 0.03 0.002* 
Prepubertal
Pubertal
Diabetic subjectsControl subjectsPDiabetic subjectsControl subjectsP
n 20 21  22 20  
Auxology       
    Sex (female/male) 10/10 10/11  10/12 10/10  
    Age (years) 9.75 ± 2.02 9.52 ± 1.94 0.662 14.64 ± 1.39 14.75 ± 1.29 0.886 
    BMI (kg/m219.70 ± 2.18 18.60 ± 2.25 0.061 23.47 ± 3.87 21.54 ± 3.19 0.128 
Laboratory tests       
    Glycemia (mg/dl) 203.35 ± 77.96 76.43 ± 8.95 0.000* 222.76 ± 104.75 77.00 ± 7.30 0.000* 
    A1C (%) 7.26 ± 0.69 5.19 ± 0.19 0.000* 7.57 ± 1.28 4.99 ± 0.29 0.000* 
    Serum creatinine (mg/dl) 0.54 ± 0.06 0.56 ± 0.07 0.734 0.69 ± 0.12 0.79 ± 0.10 0.016* 
    AER (μg/min) 5.68 ± 1.72 5.03 ± 2.87 0.090 7.83 ± 5.27 8.89 ± 2.08 0.156 
    GFR (ml/min) 142.75 ± 14.22 136.60 ± 16.38 0.188 146.93 ± 57.73 119.58 ± 9.1 0.013* 
NO       
    Serum NO (mmol/l) 30.88 ± 7.33 25.13 ± 8.06 0.026* 29.68 ± 5.79 23.74 ± 6.43 0.012* 
    Urinary NO (mmol/l) 296.47 ± 110.45 238.39 ± 59.37 0.046* 391.12 ± 172.31 296.85 ± 131.12 0.013* 
Doppler mRI 0.65 ± 0.04 0.61 ± 0.05 0.014* 0.64 ± 0.03 0.60 ± 0.03 0.002* 

Data are means ± SD.

*

P ≤ 0.05. AER, albumin excretion rate, mRI, mean RI.

Table 3—

Correlations

Diabetic subjects
Control subjects
PrPr
Serum NO     
     A1C 0.004* 0.329 0.600 −0.088 
    GFR 0.053* 0.224 0.622 −0.083 
    Diabetes duration 0.179 0.226   
    Doppler mRI 0.032* 0.262 0.427 0.141 
    Urinary NO 0.002* 0.374 0.946 0.012 
Urinary NO     
     A1C 0.000* 0.416 0.566 −0.100 
    GFR 0.000* 0.480 0.739 −0.058 
    Diabetes duration 0.238 0.199 — — 
    Doppler mRI 0.275 0.137 0.906 −0.022 
Doppler RI     
    A1C 0.000* 0.424 0.717 0.063 
    GFR 0.368 0.108 0.642 0.080 
    Diabetes duration 0.002* 0.386 — — 
Diabetic subjects
Control subjects
PrPr
Serum NO     
     A1C 0.004* 0.329 0.600 −0.088 
    GFR 0.053* 0.224 0.622 −0.083 
    Diabetes duration 0.179 0.226   
    Doppler mRI 0.032* 0.262 0.427 0.141 
    Urinary NO 0.002* 0.374 0.946 0.012 
Urinary NO     
     A1C 0.000* 0.416 0.566 −0.100 
    GFR 0.000* 0.480 0.739 −0.058 
    Diabetes duration 0.238 0.199 — — 
    Doppler mRI 0.275 0.137 0.906 −0.022 
Doppler RI     
    A1C 0.000* 0.424 0.717 0.063 
    GFR 0.368 0.108 0.642 0.080 
    Diabetes duration 0.002* 0.386 — — 
*

P ≤ 0.05, mRI, mean RI.

1.
Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, Di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A: Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.
Diabetes
49
:
1258
–1263,
2000
2.
Danne T, Kordonouri O, Hovener G, Weber B: Diabetic angiopathy in children.
Diabet Med
14
:
1012
–1025,
1997
3.
Larkins RG, Dunlop ME: The link between hyperglycemia and diabetic nephropathy.
Diabetologia
35
:
499
–504,
1992
4.
Yaqoob M, Patrick AW, McClelland P, Stevenson A, Mason H, Withe MC, Bell GM: Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin dependent diabetes mellitus.
Clin Sci
85
:
557
–562,
1993
5.
Schmidt HH, Walter U: NO at work.
Cell
78
:
919
–925,
1994
6.
Pfeilschifter J: Does nitric oxide, an inflammatory mediator of glomerular mesangial cells, have a role in diabetic nephropathy?
Kidney Int
48
:
S50
–S60,
1995
7.
Bank N, Aynedjian HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration.
Kidney Int
43
:
1306
–1312,
1993
8.
Graier WF, Simecek S, Kukovetz WR, Kostner GM: High d-glucose–induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions.
Diabetes
45
:
1386
–1395,
1996
9.
Ohta Y, Fujii K, Arima H, Matsumura K, Tsuchihashi T, Tokumoto M, Tsuruya K, Kanay H, Iwase M, Hirakata H, Iida M: Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography.
J Hypertens
23
:
1905
–1911,
2005
10.
Frauchiger B, Nussbaumer P, Hugentobler M, Staub D: Duplex sonographic registration of age and diabetes-related loss of renal vasodilatatory response to nitroglycerine.
Nephrol Dial Transplant
15
:
827
–832,
2000
11.
Ishimura E, Nishizawa Y, Kawagishi T, Okuno Y, Kogawa K, Fukumoto S, Maekawa K, Hosoi M, Inaba M, Emoto M, Morii H: Intrarenal haemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography.
Kidney Int
51
:
1920
–1927,
1997
12.
Platt JF, Rubin JM, Ellis JH: Diabetic nephropathy: evaluation with renal duplex Doppler US.
Radiology
190
:
343
–346,
1994
13.
Update on the 1987 Task Force on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program: National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.
Pediatrics
98
:
649
–658,
1996
14.
Chiarelli F, Verrotti A, Morgese G: Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children.
Pediatr Nephrol
9
:
154
–158,
1995
15.
Moshage H, Kok B, Huizenga JR: Nitrite and nitrate determinations in plasma: a critical evaluation.
Clin Chem
41
:
892
–896,
1995
16.
Green LC, Wagner DA, Glogowski L: Analysis of nitrate, nitrite and [15N] nitrate in biological fluids.
Anal Biochem
126
:
131
–138,
1982
17.
Soper CP, Barron JL, Hyer SL: Long-term glycemic control directly correlates with glomerular filtration rate in early type 1 diabetes mellitus before the onset of microalbuminuria.
Diabet Med
15
:
1010
–1014,
1998
18.
Komers R, Anderson S: Paradoxes of nitric oxide in the diabetic kidney.
Am J Physiol Renal Physiol
284
:
F1121
–F1137,
2003
19.
Lo HC, Lin SC, Wang YM: The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus.
Clin Biochem
37
:
666
–672,
2004
20.
Lane PH: Diabetic kidney disease: impact of puberty.
Am J Physiol Renal Physiol
283
:
F589
–F600,
2002
21.
Rudberg S, Ullman E, Dahlquist G: Relationship between early metabolic control and the development of microalbuminuria: a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus.
Diabetologia
36
:
1309
–1314,
1993
22.
Chiarelli F, Mohn A: Angiopathy in children with diabetes.
Minerva Pediatr
54
:
187
–201,
2002
23.
Rudberg S, Osterby R: Diabetic glomerulopathy in young IDDM patients.
Horm Res
50
:
17
–22,
1998
24.
Tublin ME, Bude RO, Platt JF: The resistive index in renal doppler sonography: where do we stand? 
180
:
885
–892,
2003
25.
Sauvain JL, Bourscheid D, Pierrat V, Cuenin E, Chavanne C, Rocq B, Chapoutot J, Ory JP, Sol F: Duplex Doppler ultrasonography of intra-renal arteries: normal and pathological aspects.
Ann Radiol
34
:
237
–247,
1991
26.
Okten A, Dinc H, Kul M, Kaya G, Can G: Renal duplex Doppler ultrasonography as a predictor of preclinical diabetic nephropathy in children.
Acta Radiol
40
:
246
–249,
1999
27.
Sperandeo M, D’Amico G, Variale A, Sperandeo G, Annese MA, Correra M: Pulsed wave color Doppler echography of the intrarenal vessels in patients with insulin-dependent diabetes mellitus and incipient nephropathy.
Arch Ital Urol Androl
68
:
183
–187,
1996
[article in Italian]
28.
Brkljacic B, Mrzljak V, Drinkovic I, Soldo D, Sabljar-Metovinovic M, Hebrang A: Renal vascular resistance in diabetic nephropathy: duplex Doppler US evaluation.
Radiology
192
:
549
–554,
1994
29.
Kuzmic AC, Brkljacic B, Ivankovic D, Galesic K: Doppler sonographic renal resistive index in healthy children.
Eur Radiol
10
:
1644
–1648,
2000

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.